BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6175767)

  • 1. Chlordecone-induced hepatic dysfunction.
    Mehendale HM
    J Toxicol Environ Health; 1981; 8(5-6):743-55. PubMed ID: 6175767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity.
    Curtis LR; Mehendale HM
    Drug Metab Dispos; 1980; 8(1):23-7. PubMed ID: 6153597
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of biotransformation in the alterations of chloroform hepatotoxicity produced by Kepone and mirex.
    Cianflone DJ; Hewitt WR; Villeneuve DC; Plaa GL
    Toxicol Appl Pharmacol; 1980 Mar; 53(1):140-9. PubMed ID: 6155715
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of halomethane hepatotoxicity: chlordecone and carbon tetrachloride.
    Mehendale HM
    Fundam Appl Toxicol; 1984 Jun; 4(3 Pt 1):295-308. PubMed ID: 6204898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the lethal interaction of chlordecone and CCl4 at non-toxic doses.
    Mehendale HM
    Toxicol Lett; 1989 Dec; 49(2-3):215-41. PubMed ID: 2481348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered hepatic energy status in chlordecone (Kepone)-potentiated CCl4 hepatotoxicity.
    Kodavanti PR; Kodavanti UP; Mehendale HM
    Biochem Pharmacol; 1990 Aug; 40(4):859-66. PubMed ID: 1696822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrastructural and biochemical correlates of the specificity of chlordecone-potentiated carbon tetrachloride hepatotoxicity.
    Curtis LR; Thureson-Klein AK; Mehendale HM
    J Toxicol Environ Health; 1981; 7(3-4):499-517. PubMed ID: 6169839
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional and biochemical correlates of chlordecone exposure and its enhancement of CCl4 hepatotoxicity.
    Davis ME; Mehendale HM
    Toxicology; 1980; 15(2):91-103. PubMed ID: 6154986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dietary exposure to a mirex plus chlordecone combination on CCl4 hepatotoxicity.
    Bell AN; Mehendale HM
    Fundam Appl Toxicol; 1985 Aug; 5(4):679-87. PubMed ID: 2412926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired biliary excretion of taurocholate associated with increased biliary tree permeability in mirex- or chlordecone-pretreated rats.
    Curtis LR; Hoyt D
    J Pharmacol Exp Ther; 1984 Dec; 231(3):495-501. PubMed ID: 6209385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term study of the combined effects of mirex, photomirex, and kepone with halogenated biphenyls in rats.
    Chu I; Villeneuve DC; Becking GC; Iverson F; Ritter L; Valli VE; Reynolds LM
    J Toxicol Environ Health; 1980 Mar; 6(2):421-32. PubMed ID: 6156243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal role of hepatocellular regeneration in the ultimate hepatotoxicity of CCl4 in chlordecone-, mirex-, or phenobarbital-pretreated rats.
    Kodavanti PR; Kodavanti UP; Faroon OM; Mehendale HM
    Toxicol Pathol; 1992; 20(4):556-69. PubMed ID: 1284994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity: a light and electron microscopic study.
    Lockard VG; Mehendale HM; O'Neal RM
    Exp Mol Pathol; 1983 Oct; 39(2):230-45. PubMed ID: 6194012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of halomethane hepatotoxicity by chlordecone: a hypothesis for the mechanism.
    Mehendale HM
    Med Hypotheses; 1990 Dec; 33(4):289-99. PubMed ID: 1708849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractional hepatic localization of 14CHCl3 in mice and rats treated with chlordecone or mirex.
    Hewitt LA; Hewitt WR; Plaa GL
    Fundam Appl Toxicol; 1983; 3(6):489-95. PubMed ID: 6198233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resiliency to amplification of carbon tetrachloride hepatotoxicity by chlordecone during postnatal development in rats.
    Cai Z; Mehendale HM
    Pediatr Res; 1993 Mar; 33(3):225-32. PubMed ID: 7681558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal relationships between biotransformation, detoxication, and chlordecone potentiation of chloroform-induced hepatotoxicity.
    Hewitt LA; Caillé G; Plaa GL
    Can J Physiol Pharmacol; 1986 Apr; 64(4):477-82. PubMed ID: 2425914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the hepatotoxicity of carbon tetrachloride following preexposure to chlordecone (kepone) in the male rat.
    Curtis LR; Williams WL; Mehendale HM
    Toxicol Appl Pharmacol; 1979 Nov; 51(2):283-93. PubMed ID: 93792
    [No Abstract]   [Full Text] [Related]  

  • 19. The time course of liver injury and [3H]thymidine incorporation in chlordecone-potentiated CHCl3 hepatotoxicity.
    Mehendale HM; Purushotham KR; Lockard VG
    Exp Mol Pathol; 1989 Aug; 51(1):31-47. PubMed ID: 2475365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlordecone potentiates hepatic fibrosis in chronic liver injury induced by carbon tetrachloride in mice.
    Tabet E; Genet V; Tiaho F; Lucas-Clerc C; Gelu-Simeon M; Piquet-Pellorce C; Samson M
    Toxicol Lett; 2016 Jul; 255():1-10. PubMed ID: 26853152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.